Fewer members, more profit: UnitedHealth shares surge on Q2 earnings beat

UnitedHealth Group on Thursday became the second major health insurer in as many days to report strong second-quarter profits, driven in part by a strategy of shrinking membership.

UnitedHealthcare's second-quarter enrollment dropped by 525,000 people quarter-over-quarter, bringing its total customer base to 48.5 million. Chief Financial Officer Wayne DeVeydt blamed the shrinking membership on rising healthcare costs that have made coverage less affordable.

UHG is the No. 1 provider of health insurance in the United States. Elevance Health is No. 2, and Wednesday reported a decline of 469,000 members from Q1.

UHG is down roughly 1.3 million members since the end of 2025. The insurer crushed expectations in Q2, reporting nearly $5.5 billion in net income. Adjusted earnings per share of $6.38 far surpassed the $4.90 forecasted by Wall Street analysts.

It continues UHG’s remarkable turnaround since former CEO Stephen Hemsley returned on May 13, 2025. Shareholders approved an unusual compensation package that eschews standard annual performance bonuses and cash incentives. Instead, Hemsley receives a $1 million annual salary and large stock options.

So far, the arrangement is working for both sides. Hemsley purchased 86,700 shares of UHG stock at $288.57 on May 16, 2025. UHG shares rose 9% early Thursday to $455.50 before buying dropped off.

“This is not just about returning to a growth rate. This is also about making this company perform in levels and in areas and spaces consistent with its mission, and to really provide a positive impact to all those and across the health system,” Hemsley told Wall Street analysts Thursday morning. “It's a journey, and it's not going to stop.”

The membership declines are attributable in part to the unwinding of Medicaid enrollment.

In 2020, federal law banned states from dropping enrollees during the COVID-19 pandemic, which pushed Medicaid enrollment to record highs. However, Congress ended this continuous coverage mandate in the spring of 2023, giving states roughly a year to audit their rosters and remove anyone who no longer qualified.

The unwinding concluded with over 25 million people losing their Medicaid coverage, driving up the national uninsured rate.

UHG executives said its Medicaid business performed largely in line with expectations during the quarter despite continued margin pressure.

Cost trends remain high

UHG executives said pricing changes, benefit redesign and care management initiatives improved Q2 performance in its Medicare business, while executives acknowledged that commercial medical cost trends remain higher than anticipated.

The company raised its adjusted earnings outlook to $19.50 to $20.00 per share for 2026 and increased its operating earnings outlook for both its UnitedHealthcare insurance division and Optum Health.

UHG’s "overall performance in the second quarter exceeded expectations, driven by better results in Medicare Advantage, while commercial benefits remain pressured,” said Tim Noel, CEO of UnitedHealthcare.

The insurer's medical care ratio, a key measure of claims costs as a percentage of premiums, improved to 86.7% from 89.4% a year earlier, aided by favorable prior-period claims development.

Medicare Advantage results were stronger than anticipated as benefit changes and care management efforts helped curb medical costs, executives said.

UnitedHealth now expects MA enrollment to decline by about 1.1 million members this year, while Medicare margins are projected to exceed 3% for 2026.

The company also said Medicare medical cost trends are now expected to come in below its original estimate of roughly 10%, citing benefit design changes, care management programs, network optimization and a milder respiratory season.

Commercial business under pressure

While Medicare improved, Noel said commercial health plans continue to experience worsening medical cost trends. Commercial medical costs are running above 11%, exceeding the company's earlier expectations.

Executives attributed the increase primarily to higher provider billing intensity and the independent dispute resolution process established under the federal No Surprises Act, which affects commercial insurance plans.

"Commercial margin recovery will remain a focus area longer than originally anticipated," Noel said.

Quarterly Highlights

• Committed to eliminating by the end of this year 30% of prior authorization volume and nearly two-thirds of prior authorization requirements for pediatric care.
• AI-powered ambient listening technology is now available to 70% of employed physicians and is expected to reach more than 90% by the end of the year.
• The AI platform, Value Connect, produced an early 17% reduction in pharmacy costs for customers.
• A transition-of-care initiative resulted in a 10% reduction in hospitalizations in pilot markets.
• Announced nationwide coverage expansion for doula care with employer-sponsored plans, with more than 7 million members eligible for coverage by January 2027.
• Eliminated 33% of drug reauthorizations – representing 11% of pharmacy prior approvals – for a list of nearly 270 chronic condition medications.
• Increased minimum payments to independent and community physicians for brand name drugs, benefiting approximately 2,300 independent and community pharmacies.

By The Numbers

• Total Revenue: $112 billion ($111.6 billion in Q2 2025)
• Net Earnings: $5.7 billion ($3.6 billion in Q2 2025)
• Earnings Per Share: Adjusted EPS of $6.38 ($4.08 in Q2 2025)
• Share Repurchases: $4 billion through Q2 2026
• Dividend Declared: $2.32 per share
• Stock Price Movement: Shares rose 9% Thursday morning before losing ground

© Entire contents copyright 2026 by InsuranceNewsNet.com Inc. All rights reserved. No part of this article may be reprinted without the expressed written consent from InsuranceNewsNet.com.

InsuranceNewsNet Senior Editor John Hilton has covered business and other beats in more than 20 years of daily journalism. John may be reached at [email protected]. Follow him on Twitter @INNJohnH.